These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24945640)

  • 1. Cantharidin: a comprehensive review of the clinical literature.
    Torbeck R; Pan M; DeMoll E; Levitt J
    Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Topical Cantharidin Treatment for Molluscum Contagiosum and Warts: A Systematic Review.
    Vakharia PP; Chopra R; Silverberg NB; Silverberg JI
    Am J Clin Dermatol; 2018 Dec; 19(6):791-803. PubMed ID: 30097988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients.
    Silverberg NB; Sidbury R; Mancini AJ
    J Am Acad Dermatol; 2000 Sep; 43(3):503-7. PubMed ID: 10954663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum.
    Moye V; Cathcart S; Burkhart CN; Morrell DS
    Dermatol Ther; 2013; 26(6):445-51. PubMed ID: 24552407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cantharidin Topical Solution 0.7%: First Approval.
    Keam SJ
    Paediatr Drugs; 2024 Jan; 26(1):95-100. PubMed ID: 38007409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cantharidin in Dermatology.
    Al-Dawsari NA; Masterpol KS
    Skinmed; 2016; 14(2):111-4. PubMed ID: 27319954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
    Eichenfield LF; McFalda W; Brabec B; Siegfried E; Kwong P; McBride M; Rieger J; Willson C; Davidson M; Burnett P
    JAMA Dermatol; 2020 Dec; 156(12):1315-1323. PubMed ID: 32965495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental satisfaction, efficacy, and adverse events in 54 patients treated with cantharidin for molluscum contagiosum infection.
    Cathcart S; Coloe J; Morrell DS
    Clin Pediatr (Phila); 2009 Mar; 48(2):161-5. PubMed ID: 18936288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cantharidin use among pediatric dermatologists in the treatment of molluscum contagiosum.
    Coloe J; Morrell DS
    Pediatr Dermatol; 2009; 26(4):405-8. PubMed ID: 19689514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.
    Eichenfield LF; Siegfried E; Kwong P; McBride M; Rieger J; Glover D; Willson C; Davidson M; Burnett P; Olivadoti M
    Am J Clin Dermatol; 2021 Mar; 22(2):257-265. PubMed ID: 33599960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Imiquimod is an Effective and Safe Drug for Molluscum Contagiosum in Children.
    Badavanis G; Pasmatzi E; Monastirli A; Georgiou S; Tsambaos D
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):164-166. PubMed ID: 28871935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood skin and soft tissue infections: new discoveries and guidelines regarding the management of bacterial soft tissue infections, molluscum contagiosum, and warts.
    Rush J; Dinulos JG
    Curr Opin Pediatr; 2016 Apr; 28(2):250-7. PubMed ID: 26900921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum.
    Moye VA; Cathcart S; Morrell DS
    Pediatr Dermatol; 2014; 31(4):450-4. PubMed ID: 24383663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients.
    Ross GL; Orchard DC
    Australas J Dermatol; 2004 May; 45(2):100-2. PubMed ID: 15068455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial.
    Guzman AK; Schairer DO; Garelik JL; Cohen SR
    Int J Dermatol; 2018 Aug; 57(8):1001-1006. PubMed ID: 29904968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cantharidin therapy for molluscum contagiosum in children.
    Epstein E
    J Am Acad Dermatol; 2001 Oct; 45(4):638. PubMed ID: 11568766
    [No Abstract]   [Full Text] [Related]  

  • 17. Cantharidin therapy: practice patterns and attitudes of health care providers.
    Pompei DT; Rezzadeh KS; Viola KV; Lee DH; Schairer DO; Chismar LA; Cohen SR
    J Am Acad Dermatol; 2013 Jun; 68(6):1045-6. PubMed ID: 23680201
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of topical cantharidin and intralesional PPD to treat molluscum contagiosum.
    Khattab FM; Nasr MM
    J Dermatolog Treat; 2020 Dec; 31(8):850-854. PubMed ID: 31418621
    [No Abstract]   [Full Text] [Related]  

  • 19. Cantharidin treatment for recalcitrant facial flat warts: a preliminary study.
    Kartal Durmazlar SP; Atacan D; Eskioglu F
    J Dermatolog Treat; 2009; 20(2):114-9. PubMed ID: 18821118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.
    Coloe Dosal J; Stewart PW; Lin JA; Williams CS; Morrell DS
    Pediatr Dermatol; 2014; 31(4):440-9. PubMed ID: 22897595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.